While health tech is not set to drive pharma out of business, it is essential that the industry incorporates it into future strategies.

It is time for the pharmaceutical industry to recognise their duty of care to the planet as well as patients, and drastically reduce their carbon footprint.

Amidst the public discourse surrounding sustainability and ethical practices, is the problem of pharmaceutical waste. It is imperative that the pharmaceutical industry actively seeks solutions.

Dr Terri L. Phillips, Vice President and Head Global Medical Affairs, Merz, speaks to us about championing women in the workplace, her experience in the US army medical corps, and the changing nature of medical affairs.

Globally, 5 billion people have access to medication, leaving 2 billion, predominantly in the developing world, who do not. As a challenge that only continues to grow in complexity, with ever-changing regulations and continual development of treatments, market access appears to be the pharmaceutical industry’s mission impossible

Over the past two centuries, the landscape of pharmaceutical marketing has transformed almost beyond recognition. We reflect on the propelling reasons behind such metamorphic change and consider the impact of emerging platforms: from print to radio and from TV to online.

Low levels of return on investment in R&D is an issue that has been bubbling beneath the surface of pharmaceutical companies for some time and the situation is coming to a head, threatening the industry’s future

Patient recruitment and retention remain the biggest challenges in clinical studies, it is surely time for industry to trial a new approach.